Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

A Pilot Trial of Pre-Transplant Risk Stratification and Prophylactic Defibrotide to Prevent Serious Thrombotic Microangiopathy in High-Risk Pediatric Hematopoietic Stem Cell Transplant Patients

Christine S Higham, Alexis Melton, MD PhD, Sandhya Kharbanda, MD, Jasmeen Dara, MD, Lena E. Winestone, MD, James N Huang, MD, Kristin A. Shimano, MD

Blood (2020) 136 (Supplement 1): 9–10.

https://doi.org/10.1182/blood-2020-140475

Published: 2020

Journal Articles

Reduced Toxicity Conditioning for Non-Malignant Hematopoietic Cell Transplants

Cristina F Contreras, BS, Janel R Long-Boyle, PharmD, PhD, Kristin A. Shimano, MD, Jasmeen Dara, MD, James N Huang, MD, Sandhya Kharbanda, MD, Alexis Melton, MD PhD, Christine Higham, MD, Morton J Cowan, MD, Christopher C. Dvorak, MD

Blood (2019) 134 (Supplement_1): 4481.

https://doi.org/10.1182/blood-2019-127218

Published: 2019

Journal Articles

Role of Disease Mechanism in Hematopoietic Cell Transplantation Outcomes for Hemophagocytic Lymphohistiocytosis

Aleksandra S. Dain, MD, Michelle L. Hermiston, MD PhD, Kristin A. Shimano, MD, Sandhya Kharbanda, MD, Alexis Melton, MD PhD, Jasmeen Dara, MD, James N Huang, MD, Christopher C. Dvorak, MD

Blood (2019) 134 (Supplement_1): 3343.

https://doi.org/10.1182/blood-2019-127397

Published: 2019

Journal Articles

Azacitidine Administration Following Hematopoietic Stem Cell Transplantation Is Safe and Feasible in Children with Acute Leukemia

Justin T. Wahlstrom, MD, Biljana N. Horn, MD, Carol Fraser-Browne, Rebecca Hoeweler, Ying Lu, PhD, Alexis Melton, MD PhD, Jennifer Willert, MD, Christopher C. Dvorak, MD

Blood (2016) 128 (22): 4805.

https://doi.org/10.1182/blood.V128.22.4805.4805

Published: 2016

Journal Articles

Daratumumab Is Effective in the Treatment of Refractory Post-Transplant Autoimmune Hemolytic Anemia: A Pediatric Case Report

Vanessa P. Tolbert, MD, Robert Goldsby, MD, James Huang, MD, Kristin Shimano, MD, Alexis Melton, MD PhD, Jennifer Willert, MD, Biljana N. Horn, MD, Christopher C. Dvorak, MD, Justin T. Wahlstrom, MD

Blood (2016) 128 (22): 4819.

https://doi.org/10.1182/blood.V128.22.4819.4819

Published: 2016

NARROW

A Pilot Trial of Pre-Transplant Risk Stratification and Prophylactic Defibrotide to Prevent Serious Thrombotic Microangiopathy in High-Risk Pediatric Hematopoietic Stem Cell Transplant Patients

Reduced Toxicity Conditioning for Non-Malignant Hematopoietic Cell Transplants

Role of Disease Mechanism in Hematopoietic Cell Transplantation Outcomes for Hemophagocytic Lymphohistiocytosis

Azacitidine Administration Following Hematopoietic Stem Cell Transplantation Is Safe and Feasible in Children with Acute Leukemia

Daratumumab Is Effective in the Treatment of Refractory Post-Transplant Autoimmune Hemolytic Anemia: A Pediatric Case Report

Email alerts

ASH Publications

American Society of Hematology

A Pilot Trial of Pre-Transplant Risk Stratification and Prophylactic Defibrotide to Prevent Serious Thrombotic Microangiopathy in High-Risk Pediatric Hematopoietic Stem Cell Transplant Patients

Reduced Toxicity Conditioning for Non-Malignant Hematopoietic Cell Transplants

Role of Disease Mechanism in Hematopoietic Cell Transplantation Outcomes for Hemophagocytic Lymphohistiocytosis

Azacitidine Administration Following Hematopoietic Stem Cell Transplantation Is Safe and Feasible in Children with Acute Leukemia

Daratumumab Is Effective in the Treatment of Refractory Post-Transplant Autoimmune Hemolytic Anemia: A Pediatric Case Report

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only